Balyasny Asset Management »

Centessa Pharmaceuticals shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $11M 681k 15.99
2024-06-30 $9.2M 1.0M 9.03
2024-03-31 $2.9M 254k 11.30

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Microsoft Corporation Call Option (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Financial (XLF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Alphabet Cap Stk Cl A (GOOGL)
Amazon Call Option (AMZN)
Discover Financial Services Call Option (DFS)
Select Sector Spdr Tr Energy (XLE)
Meta Platforms Cl A Call Option (META)
Kellogg Company Call Option (K)
Hess Call Option (HES)

View all positions for Balyasny Asset Management

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
General Atlantic
Perceptive Advisors
First Light Asset Management
T. Rowe Price Associates
Adage Capital Partners GP
Vida Ventures Advisors
T. Rowe Price Investment Management
Siren
EcoR1 Capital
FMR
TCG Crossover Management
Farallon Capital Management
Point72 Asset Management
Cormorant Asset Management

View all funds holding Centessa Pharmaceuticals